Clinical trial
Cross Sectional Study of Vaccine Antibody Response in Inflammatory Bowel Disease Patients
NCT02434133 is registered in ClinicalTrials.gov with University of Wisconsin, Madison as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Cross Sectional Study of Vaccine Antibody Response in Inflammatory Bowel Disease Patients
- Lead sponsor
- University of Wisconsin, Madison
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 30, 2015
- Completion date
- December 31, 2017
- Enrollment
- 110 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
inflammatory bowel disease (ibd)